Nachrichten zur JOHNSON MATT. LS 1,101698 Aktie

Johnson & Johnson beats quarterly revenue estimates, maintains full-year outlook

Johnson & Johnson (NYSE:JNJ) reported first-quarter results on Tuesday that beat Wall Street expectations for revenue, driven by solid growth…

1 Stock to Buy, 1 Stock to Sell This Week: Netflix, Johnson & Johnson

Market Analysis by covering: SPDR® S&P 500® ETF Trust, Invesco QQQ Trust, Johnson & Johnson, Netflix Inc. Read s…

HURA: 2025 Financial Results

By John Vandermosten, CFANASDAQ: HURAREAD THE FULL HURA RESEARCH REPORTOperational and Financial ResultsOn April 1st, 2026, TuHURA Biosciences, Inc. (NASDAQ:…

Gear Up for Johnson & Johnson (JNJ) Q1 Earnings: Wall Street Estimates for Key Metrics

Besides Wall Streets top-and-bottom-line estimates for Johnson & Johnson (JNJ), review projections for some of its key metrics to gain…

Johnson & Johnson Aktie: Kaufchance! Beginnt jetzt die nächste Wachstumsphase?

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Goldman Sachs:Goldman Sachs bestätige vor den Ergebnissen zum ersten Quartal das "buy"-Votum…

Johnson & Johnson Aktie: Höheres Kursziel trotz Branchenunsicherheit

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Citi:Die Analysten von Citi haben das Kursziel für die Aktie von Johnson…

Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know

Johnson & Johnson (JNJ) closed at $241.3 in the latest trading session, marking a +1.21% move from the prior day.…

Johnson & Johnson: Success In Multiple Myeloma Underpins $25B In Growth By 2030

…

Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing

Johnson & Johnson (JNJ) closed the most recent trading day at $239.93, moving +1.98% from the previous trading session.…

The Zacks Analyst Blog JPMorgan, Johnson & Johnson, Applied Materials and Value Line

JPMorgan, Johnson & Johnson and Applied Materials stand out in new research reports, highlighting strong business momentum despite industry and…

JNJ Seeks Label Expansion of Multiple Myeloma Drug Tecvayli in the EU

Johnson & Johnson seeks EMA nod to expand Tecvayli monotherapy use in earlier-line RRMM, backed by phase III MajesTEC-9 data…

Johnson & Johnson Aktie: Medizintechnik-Sektor weiter in starker Verfassung

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Citigroup:Citi habe das Kursziel für die Aktie von Johnson & Johnson (J&J)…

Scherbaums Börse: Die Stärke von Johnson & Johnson

Donald Trump zwingt Pharmakonzerne zu Preisnachlässen. Doch ausgerechnet Johnson & Johnson liefert überraschend starke Zahlen. Anleger stellen sich nun eine…

Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $239.63, denoting a -2.31% move from…

Johnson & Johnson launches website for direct-to-consumer sales

Johnson & Johnson has launched a website to sell some of its drugs directly to U.S. patients who either dont…

Johnson & Johnson launches website for direct-to-consumer sales

Johnson & Johnson launches website for direct-to-consumer sales…

Johnson & Johnson Aktie: BofA sieht mehr Umsatzpotenzial - Fokus auf Tecvayli und Inlexzo

Charlotte (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von BofA Securities:Jason Gerberry, Analyst von BofA Securities, stuft die Aktie von Johnson &…

Johnson & Johnson (JNJ) Advances While Market Declines: Some Information for Investors

Johnson & Johnson (JNJ) closed the most recent trading day at $248.43, moving +2.04% from the previous trading session.…

Bayer verklagt Johnson & Johnson – Aktie fällt und fällt

Der DAX-Konzern Bayer will sich in den Vereinigten Staaten juristisch gegen Johnson & Johnson wehren. Der Hintergrund für die Klage…

Bayer verklagt Johnson & Johnson – Aktie fällt und fällt

Der DAX-Konzern Bayer will sich in den Vereinigten Staaten juristisch gegen Johnson & Johnson wehren. Der Hintergrund für die Klage…

Bayer verklagt Johnson & Johnson wegen irreführender Werbung

Von Nicholas G. Miller DOW JONES--Die Bayer AG verklagt Johnson Johnson (JJ) und deren Sparte Janssen Biotech wegen…

Johnson & Johnson vs. AbbVie: A Growth Showdown Amid Patent Cliffs

JNJs diversified model, $32B R&D push and 48% stock surge in a year raise the stakes in its battle with…

Johnson & Johnson: This Dividend King Could Anchor a Millionaire Retirement Portfolio

Its about striking that perfect balance between chasing growth and protecting what you already have.…

Honeywell Considers Walking Away From Johnson Matthey Catalyst Deal

Honeywell International Inc. is considering walking away from its acquisition of Johnson Matthey Plc’s Catalyst Technologies business, people familiar with…

Why Is Johnson & Johnson (JNJ) Up 13% Since Last Earnings Report?

Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports By Reuters

Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports…

Johnson & Johnson prepares to sell orthopedics unit for over $20 billion

Johnson & Johnson prepares to sell orthopedics unit for over $20 billion - Bloomberg…

Johnson & Johnson to invest $1B in Pennsylvania manufacturing facility

Johnson & Johnson announced a $1 billion investment in a Montgomery County, Pennsylvania, cell therapy facility that will yield over…

Johnson & Johnson investing $1B to build new cell therapy facility in Montgomery County

Johnson & Johnson is investing more than $1 billion to build a new cell therapy plant in Montgomery County.…

Johnson & Johnson to Invest More Than $1 Billion in Pennsylvania Cell Therapy Factory

The facility is part of the company’s plans to invest $55 billion in U.S. manufacturing, research and development and technology…

J&J to invest $1 billion in new Pennsylvania plant amid US manufacturing push

Johnson & Johnson said on Wednesday it will invest more than $1 billion to build a new cell therapy facility…

Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania

• Advanced manufacturing site will utilize cutting?edge cell therapy technologies to help deliver the company’s portfolio of transformational medicines •…

dpa-AFX ProFeed